(Q40411986)

English

Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12.

scientific article published on August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

vector-borne disease

0 references

Semliki Forest virus

0 references

Brian J. Sheahan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Chikkanna-Gowda CP

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Fleeton MN

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Atkins GJ

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1253-1263

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302561

0 references

Alphavirus vectors for gene therapy applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Alphavirus vectors for vaccine production and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Alphavirus vectors and vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Semliki Forest virus vectors: efficient vehicles for in vitro and in vivo gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

The Semliki Forest virus vector induces p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Alphaviruses and their derived vectors as anti-tumor agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

21 January 2018

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

7 January 2021

based on heuristic

inferred from DOI database lookup

HSV-1 therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

7 January 2021

based on heuristic

inferred from DOI database lookup

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302561

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302561

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15944731%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40411986&oldid=1568442857"